Navigation Links
Argonne scientists discover possible mechanism for creating 'handedness' in biological molecules
Date:12/1/2008

ARGONNE, Ill. (December 1, 2008) The basic molecules that make up all living things have a predetermined chirality or "handedness," similar to the way people are right- or left-handed. This chirality has a profound influence on the chemistry and molecular interactions of living organisms. The inception of chirality from the elementary building blocks of matter is one of the great mysteries of the origin of life. Scientists at the U.S. Department of Energy's Argonne National Laboratory have discovered a way to induce this handedness in pre-biological molecules.

"Understanding how the molecules necessary for life originated is one of the most basic scientific questions in biochemistry," Argonne chemist Richard Rosenberg said. "Chirality plays a fundamental role in biological processes and researchers have been trying to discover the mechanisms that led to this property for years."

Rosenberg used X-rays from the Advanced Photon Source to bombard chiral molecules adsorbed on a magnetic substrate and x-ray photoelectron spectroscopy to track changes in the molecular bonds.

He found that changing the magnetization direction in relation to the high-intensity X-ray beam created an excess of one chirality over another. Changing the magnetization direction reverses the spin polarization of the secondary, or low-energy, electrons emitted from the substance.

Iron is a common element and is magnetic in many form and ionizing radiation and magnetic fields are prevalent throughout the universe.

Based on the Argonne results, it is conceivable that chirality could have been introduced by irradiation of molecules as they traveled through the universe while adsorbed on a magnetized substrate in a dust cloud, meteor, comet or on a primitive planet.

"Our study shows that spin-polarized secondary electrons interacting with chiral molecules could produce a significant excess of a given chirality in pre-biological molecules," Rosenberg sa
'/>"/>

Contact: Brock Cooper
bcooper@anl.gov
630-252-5565
DOE/Argonne National Laboratory
Source:Eurekalert

Page: 1 2

Related biology news :

1. Argonne helps China create cleaner Beijing for 2008 Olympics
2. Argonne National Lab acquires first SiCortex SC5832
3. New Argonne study may shed light on protein-drug interactions
4. Research at Argonnes Advanced Photon Source reveals structure and behavior of collagen
5. Bioinformatics technology developed at Argonne provides new insight into microbial activities
6. Argonne scientists develop techniques for creating molecular movies
7. Argonne scientists use lasers to align molecules
8. Argonne-SRNL agreement supports critical DOE, national priorities
9. Argonne-University of Chicago joint venture bolsters genomic sequencing capabilities
10. Integrated Fuel Technologies gets worldwide license for Argonne-developed Diesel DeNOx Catalyst
11. NIH awards Argonne $800,000 to develop tool to measure distances within proteins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... inspired a 3.2m, three-year research project that...ecurity, energy and the environment. The Universit...inetiQ have just signed a collaborative contract t... physical sciences research. , Over the next th... of Exeter and QinetiQ will work together to devel...
(Date:11/9/2009)...eaders from around the world will gather in Boston...r Targets and Cancer Therapeutics International Co...ation on important cancer therapies in development...t effectively we need a greater understanding of t...l," said Lewis Cantley, Ph.D., director of the can...
(Date:11/8/2009)...S WITH INTELLECTUAL DISABILITIES: AN OPPORTUNITY F...y involving adults with intellectual disabilities ...lth knowledge after taking a semi-weekly class for...ly accepted term for mental retardation, have slig...and preventable chronic diseases compared to the g...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Nevada Drug Card and Las Vegas Chamber Offer Rx Assistance 52973 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 3Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 4New drug for children with high risk leukemia 52965 1New drug for children with high risk leukemia 52965 2
... of a sustainable biofuels industry in Tennessee h... of Energy has announced that Mascoma Corporation,...cipients of a $26 million grant for the developmen...s for demonstrating the production of cellulosic e... operations. The facility is to be constructed at ...
..., including malaria, dengue fever, and avian influ...l factors and, more recently, to climate change. R...e animals that carry and ultimately transmit these...occurs, these diseases may be introduced into area...standing the interactions that occur among climate...
...nse of Arctic sea ice is increasingly vulnerable t...dy, by scientists at the National Center for Atmos...ty (CSU), finds that unusually sunny weather contr... while similar weather conditions in past summers ...he study, which draws on observations from instrum...
Other Biology News:Mascoma and UT join in $26M DOE grant 2Mascoma and UT join in $26M DOE grant 3Scientists to explore global change-public health connection 2Arctic ice more vulnerable to sunny weather, new study shows 2Arctic ice more vulnerable to sunny weather, new study shows 3
(Date:11/5/2009)...ORDOVA, Calif., Nov. 5 T...plier of innovative products for processing and st... the first quarter of fiscal 2010. ,, For the q...ted revenues of $5.2 million, a 15 percent increas...er a year ago. The Company said the key contributo...
(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
(Date:11/5/2009)...O, CA, November 5, 2009 ...on using proprietary taste receptor-based technolo...food, beverage, and ingredient supply industries, ...ancial results for the third quarter ended Septemb...hird quarter of 2009, compared to $4.0 million for...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...RDAM, The Netherlands, February 11, Agendia, a wor...nounced the appointment of Alan B. Carter as the c...elopment. , "As we continue to grow as a globa...primary aims," commented Dr. Bernhard Sixt, Ph.D.,...sive business development expertise will,strengthe...
... (Pink Sheets: MNCN), a global health company that...ce positive, long term benefit to the agricultural... executed its definitive agreement to acquire Modu...ice of $500,000 in the form of Convertible Preferr...will allow Mach One to bring in house the engineer...
...A team of Los Alamos researchers led by Victor Kli...oton creates multiple electronsis a real phenomeno...bservation born of extraneous effects that mimic c...a recent issue of Accounts of Chemical Research ,...more than one unit of energy per photon. , Questi...
Other Biology Technology:Agendia Appoints VP of Business Development 2Mach One Executes Definitive Agreement to Acquire Biopharmaceutical Design & Engineering Firm 2Research highlights potential for improved solar cells 2Research highlights potential for improved solar cells 3
HV Mini 5 (230V / 50Hz) from Thermo Scientific
Immulon 1 B 1x12 Strip from Thermo Scientific
Peptides from Thermo Scientific
RapidStak 2 (requires 4 staks, not included) from Thermo Scientific
Biology Products: